
APIs for research and impurities
Active Pharmaceutical Ingredients (APIs) are the substances in drugs responsible for their therapeutic effects. In this section, you will find a wide variety of APIs intended for research use. These compounds are essential for the development, testing, and validation of new pharmaceutical formulations. CymitQuimica offers high-quality APIs to support research in drug discovery and development.
Subcategories of "APIs for research and impurities"
- Alkaloids
- Aminoacids and derivatives
- Anthraquinones and derivatives
- Benzimidazole and Imidazole Derivatives
- Benzodiazepine Derivatives
- Carbohydrates and glycoconjugates
- Esters and Derivatives
- Fatty Acids and Lypidic Derivatives
- Flavonoids and Polyphenols
- Free Radicals and Oxidant/Reducing Agents
- Ketones and derivatives
- Natural and semi-synthetic antibiotics
- Nitriles and Cyano Derivatives
- Nitrosamines and Derivatives
- Nucleosides and Nucleotides
- Organic Phosphates and Phosphonates
- Organic Sulphonates and Sulphates
- Organometallics
- Others
- Peptides and Proteins
- Polymers and Derivatives
- Purines and Pyrimidine Derivatives
- Quinazoline and Quinoline Derivatives
- Quinones and Derivatives
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
- Steroids and Derivatives
- Sulfonamides and Derivatives
- Terpenoids and Derivatives
- Thiazolidinediones and Thiopyrans
- β-Adrenergic Compounds
Show 22 more subcategories
Products of "APIs for research and impurities"
Sort by
6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
CAS:6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is a metabolite that can be found in the urine and blood of humans. It has been shown to have cytotoxic effects on human lymphocytes and erythrocytes. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is used as an impurity standard for HPLC analysis and as a reference compound for pharmacopoeia. This chemical is also used in the synthesis of some drugs. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is not listed in any pharmacopoeia or natural product database.Formula:C9H7Cl2N5Purity:Min. 95%Color and Shape:White PowderMolecular weight:256.09 g/molUrea, N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-
CAS:Formula:C11H12N2O2SPurity:97%Color and Shape:SolidMolecular weight:236.2902Acetamide, N-(4-methoxy-2-nitrophenyl)-
CAS:Formula:C9H10N2O4Purity:98%Color and Shape:SolidMolecular weight:210.18674-(N-Methyl-N-nitrosamino)-1-(pyridin-3-yl)-1-butanone (NNK) (N-methyl-N-(4-oxo-4-(pyridin-3-yl)butyl)nitrous amide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C10H13N3O2Color and Shape:Off-White Fine PowderMolecular weight:207.10078Ref: 4Z-I-1713
Discontinued productIobitridol (>90%)
CAS:Applications Diagnostic aid (radiopaque medium). References Bourrinet, P., et al.: Invest. Radiol., 29, 1057 (1994), Donadieu, A.-M., et al.: Acta Radiol., 37, 400 (1996),Formula:C20H28I3N3O9Purity:>90%Color and Shape:NeatMolecular weight:835.16[1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, (αR,γS)-
CAS:Formula:C22H25NO5Purity:97%Color and Shape:SolidMolecular weight:383.43762'-Deoxy-5,6-didehydro-2',2'-difluoro-6-hydroxyuridine
2'-Deoxy-5,6-didehydro-2',2'-difluoro-6-hydroxyuridine is an analytical standard that is used in research and development of drugs. This compound has been designated as an impurity in a drug product. It has also been used as a reference standard for HPLC analysis. 2'-Deoxy-5,6-didehydro-2',2'-difluoro-6-hydroxyuridine is a metabolite of the drug product. This compound is not found in nature and has been synthesized artificially.Formula:C9H12F2N2O6Purity:Min. 95%Molecular weight:282.2 g/molChlorambucil EP Impurity G (ortho Chlorambucil)
CAS:Formula:C14H19Cl2NO2Color and Shape:Yellow SolidMolecular weight:304.21Lornoxicam Impurity 12
CAS:Formula:C9H8ClNO5S2Color and Shape:Pale Yellow SolidMolecular weight:309.74Des(oxopentyl) Valsartan
CAS:Controlled ProductImpurity Valsartan Desvaleryl Impurity Applications An impurity in the synthesis of Valsartan (V095750). References Carini, D., et al.: J. Med. Chem., 34, 2525 (1991), Buhlmayer, P., et al.: Bioorg. Med. Chem. Lett., 4, 29 (1994),Formula:C19H21N5O2Color and Shape:WhiteMolecular weight:351.40Cephalosporin Impurity 5
CAS:Formula:C24H24N2O5SColor and Shape:White To Off-White SolidMolecular weight:452.532-TERT-BUTOXYCARBONYLAMINO-ACRYLIC ACID METHYL ESTER
CAS:Formula:C9H15NO4Purity:97%Color and Shape:LiquidMolecular weight:201.2197Formoterol Impurity 5
CAS:Formula:C19H24N2O3Color and Shape:White To Off-White SolidMolecular weight:328.41Phosphonic acid, P,P'-(1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-
CAS:Formula:C9H12N2O7P2Purity:95%Color and Shape:SolidMolecular weight:322.1483Bromocriptine EP Impurity D
CAS:Formula:C16H15BrN2O2Color and Shape:Grey SolidMolecular weight:347.21Alloc bromoridane
CAS:Alloc bromoridane is a drug product that contains the active ingredient bromoridane. Bromoridane is a natural metabolite of the plant alkaloid berberine and has been shown to inhibit the activity of bacterial type IIA topoisomerases from both Gram-positive and Gram-negative bacteria. The chemical name for Alloc bromoridane is 2-[2-(4-bromobenzoyl)phenyl]dihydropyrimidine, and it has CAS number 117348-70-6. Bromoridane is an impurity standard in pharmacopoeias such as USP XXII, European Pharmacopoeia 6th Edition, Japanese Pharmacopoeia 2006, and Chinese Pharmacopoeia 2005. Alloc bromoridane is used in research and development for pharmaceuticals or as an analytical reference material.Formula:C13H20BrNO4Purity:Min. 95%Molecular weight:334.21 g/molAcetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
CAS:Formula:C16H14N2O3Purity:97%Color and Shape:SolidMolecular weight:282.29396Manidipine dihydrochloride
CAS:Formula:C35H38N4O6·2HClPurity:≥ 98.0%Color and Shape:White to pale yellow powder or crystalsMolecular weight:683.63Cetirizine Sorbitol Ester Impurity HCl (Mixture of Diastereomers)
CAS:Formula:C27H37ClN2O8·HClColor and Shape:White To Off-White SolidMolecular weight:553.05 36.46(Z)-Fluvoxamine - EP
CAS:Controlled Product(Z)-Fluvoxamine-EP is a drug product that is used as an analytical standard. It is a synthetic metabolite of fluvoxamine, which is a drug used for the treatment of depression. The synthesis of (Z)-fluvoxamine-EP is based on the asymmetric synthesis of fluvoxamine and the use of chiral chromatography to purify the product. This synthetic process allows for the production of high-purity (Z)-fluvoxamine-EP with a purity greater than 99%.Formula:C15H21F3N2O2Purity:Min. 95%Molecular weight:318.33 g/molKetoconazole-d3
CAS:Controlled ProductApplications Ketoconazole-d3 is the labeled analogue of Ketoconazole (K186000), which inhibits cytochrome P-450 dependent steps in the biosynthesis of steroid hormones in vivo. Antimetastatic and antineoplastic activity. Orally active 5-lipoxygenase and thromboxane synthase inhibitor. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Lambert, A., et al.: Biochem. Pharmacol., 35, 3999 (1986); Van Wauwe, J.P. and Janssen, P.A.J., J. Med. Chem., 32, 2231 (1989); Nardone, P.A., et al.: . Surg. Res., 44, 425 (1988); Tucker, W.F.G., et al.: Br. Med. J., 293, 882 (1986)Formula:C26H25D3Cl2N4O4Color and Shape:NeatMolecular weight:534.459(10H)-Anthracenone, 1,8-dihydroxy-
CAS:Formula:C14H10O3Purity:93%Color and Shape:SolidMolecular weight:226.2274Isavuconazole Impurity 5 Chloride DiHCl (Mixture of Diastereomers)
Formula:C35H35F2N8O5S·Cl·2HClColor and Shape:Off-White SolidMolecular weight:717.77 35.45 2*36.46Tolfenamic Acid-d4
CAS:Controlled ProductApplications Labelled Tolfenamic Acid. Non-steroidal anti-inflammatory drugs (NSAIDs). A derivative of anthranilic acid, related structurally to Mefenamic and Flufenamic acids. Anti-inflammatory, analgesic. References Pentikaeinen, P., et al.: Eur. J. Clin. Pharmacol., 19, 359 (1981), Bundscherer, A., et al.: Oncol. Rep., 19, 547 (2008), Elwood, P., et al.: Lancet, 373, 1301 (2009),Formula:C14D4H8ClNO2Color and Shape:NeatMolecular weight:265.73Triacetic Acid Impurity 2 (Ethylenediamine-N,N'-diacetic acid)
CAS:Formula:C6H12N2O4Molecular weight:176.17TERT-BUTYL 7-METHYL-5-OXO-1,4-DIAZEPANE-1-CARBOXYLATE
CAS:Purity:95.0%Molecular weight:228.29200744628906Procaterol Impurity 10 (Mixture of Diastereomers)
Formula:C16H22N2O2Color and Shape:Pale Yellow SolidMolecular weight:274.36Sodium (S)-6-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
CAS:Formula:C16H14F2N3NaO4SPurity:99%Color and Shape:SolidMolecular weight:405.35163639999996Cephapirin Sodium
CAS:Controlled ProductApplications Sodium salt of Cephapirin (C261500), an antimicrobial agent. References Tan, J.S., et al.: Antimicrob. Agents Chemother., 15, 510 (1979),Formula:C17H16N3O6S2·NaColor and Shape:NeatMolecular weight:445.45Ezetimibe Impurity 85
Formula:C31H27F2NO3Color and Shape:White To Off-White SolidMolecular weight:499.56N-Methyl-2-(pyridin-2-yl)ethanamine methanesulfonate
CAS:Formula:C10H20N2O6S2Purity:98%Color and Shape:SolidMolecular weight:328.40560000000005Roflumilast Impurity 7
Formula:C17H14BrClF2N2O3Color and Shape:White To Off-White SolidMolecular weight:447.66Miproxifene
CAS:Controlled ProductApplications Miproxifene is an active metabolite of TAT-59 against human breast cancer. References Toko, T., et al.: Cancer Chemo. Pharm., 39, 390 (1997); Matsunaga, Y., et al.: Chem. Pharm. Bull., 42, 2582 (1994)Formula:C29H35NO2Color and Shape:NeatMolecular weight:429.59Deferasirox Impurity 4
Formula:C14H11NO4Color and Shape:White To Off-White SolidMolecular weight:257.2513-Ethyl-3-methoxygona-2,5(10)-dien-17β-ol
CAS:Controlled ProductPlease enquire for more information about 13-Ethyl-3-methoxygona-2,5(10)-dien-17β-ol including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C20H30O2Purity:Min. 95%Molecular weight:302.5 g/molSodium 3-methyl-2-oxopentanoate
CAS:Formula:C6H9NaO3Purity:98%Color and Shape:SolidMolecular weight:152.1236Gentamicin sulfate
CAS:Formula:C60H127N15O26SColor and Shape:White to off-white powderMolecular weight:575.67Ref: 4Z-A-194006
Discontinued productPhenol,2,2'-[6-(4-methoxyphenyl)-1,3,5-triazine-2,4-diyl]bis[5-[(2-ethylhexyl)oxy]-
CAS:Formula:C38H49N3O5Purity:97%Color and Shape:SolidMolecular weight:627.8128D-Threo-3,4-dihydroxyphenylserine hydrochloride
CAS:Please enquire for more information about D-Threo-3,4-dihydroxyphenylserine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C9H11NO5Purity:Min. 95%Molecular weight:213.19 g/mol4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
CAS:Formula:C10H11N3O3SPurity:95%Color and Shape:SolidMolecular weight:253.27762-Pyridinamine, 4-methoxy-
CAS:Formula:C6H8N2OPurity:98%Color and Shape:SolidMolecular weight:124.1405Uridine 5'-(trihydrogen diphosphate), sodium salt (1:2)
CAS:Formula:C9H12N2Na2O13P2Purity:96%Color and Shape:SolidMolecular weight:464.1242Semaglutide Impurity 104 Trifluororacetate(Des Ser 8)
Formula:C184H286N44O57·C2HF3O2Molecular weight:4026.56 114.02Luminespib (AUY-922, NVP-AUY922)
CAS:Formula:C26H31N3O5Purity:98%Color and Shape:SolidMolecular weight:465.5414[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl][(5S)-tetrahydro-5-methyl-2-furanyl]-methanone
CAS:Furegrelate is an analytical reference standard for the hydroxylation of 4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl[(5S)-tetrahydro-5-methyl-2-furanyl]-methanone. Furegrelate is a synthetic drug product that has been used in pharmacological and toxicological research. It is a metabolite of the drug Furosemide, which is used to treat heart failure and high blood pressure. Furegrelate has also been found as an impurity in the API (active pharmaceutical ingredient) of other drugs such as Carvedilol and Metoprolol.Formula:C20H27N5O4Purity:Min. 95%Molecular weight:401.46 g/molDocosahexaenoic Acid
CAS:Controlled ProductStability Air Sensitive, Light Sensitive Applications Omega-3 fatty acid found in marine fish oils and in many phospholipids. Major structural component of excitable membranes of the retina and brain; synthesized in the liver from α-linolenic acid. Nutritional supplement. References Whitcutt, J.M., et al.: Biochem. J., et al.: 67, 60 (1957), Bazan, N.G., et al.: J. Ocul. Pharmacol., 10, 591 (1994), Makrides, M., et al.: Lipids, 31, 115 (1996),Formula:C22H32O2Color and Shape:Colourless To Light YellowMolecular weight:328.49Peramivir Impurity 29
CAS:Formula:C15H28N4O4Color and Shape:White To Off-White SolidMolecular weight:328.41Tirzepatide Impurity 46 Ditrifluoroacetate (Endo-Pro 36/37/38)
Formula:C230H355N49O69·2C2HF3O2Molecular weight:4910.64 2*114.02b-Alanine, N-methyl-N-pentyl-, hydrochloride
CAS:Formula:C9H20ClNO2Purity:97%Color and Shape:SolidMolecular weight:209.7136Cyclophosphamide Impurity 31
CAS:Formula:C8H17Cl2N2O2PColor and Shape:White To Off-White Semi-SolidMolecular weight:275.12Ganciclovir Impurity 1 HCl (Mixture of Diastereomers)
CAS:Formula:C15H24N6O5·HClColor and Shape:White To Off-White SolidMolecular weight:368.39 36.463-Bromo-5-fluoro-4-hydroxybenzaldehyde
CAS:Formula:C7H4BrFO2Purity:95%Color and Shape:SolidMolecular weight:219.00791-Ethyl-3-methylimidazolium Aminoacetate
CAS:Formula:C8H15N3O2Purity:95%Color and Shape:LiquidMolecular weight:185.2236Baricitinib Impurity 5
Formula:C26H29N11O4S2Color and Shape:White To Off-White SolidMolecular weight:623.71Atovaquone Impurity 3 (Mixture of cis and trans Isomers)
CAS:Formula:C14H17ClOColor and Shape:White To Off-White SolidMolecular weight:236.74D-Glucose, 2-deoxy-2-fluoro-
CAS:Formula:C6H11FO5Purity:98%Color and Shape:SolidMolecular weight:182.14694319999995Dapagliflozin Impurity 32
CAS:Formula:C23H27ClO7Color and Shape:White To Off-White SolidMolecular weight:450.91Propiverine Hydroxy Impurity
CAS:Formula:C20H23NO3Color and Shape:White To Off-White SolidMolecular weight:325.412-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfonyl)methyl)-3,4-dimethoxypyridine 1-oxide
CAS:Formula:C16H15F2N3O6SPurity:95%Color and Shape:SolidMolecular weight:415.3686Rocuronium Bromide EP Impurity B Bromide
CAS:Formula:C34H55N2O5·BrColor and Shape:White To Off-White SolidMolecular weight:571.82 79.90N2-Nitroso Lacosamide EP Impurity F (R-Isomer) (N2-Nitroso Lacosamide USP Related Compound F (R-Isomer))
Formula:C12H15N3O4Molecular weight:265.27Ibuprofen Isopropyl Ester
CAS:Formula:C16H24O2Purity:97%Color and Shape:LiquidMolecular weight:248.3606METHYL PERFLUOROOCTANOATE
CAS:Formula:C9H3F15O2Purity:97%Color and Shape:LiquidMolecular weight:428.095Bis-[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]disulfide
CAS:Bis-[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]disulfide is a disulfide derivative of famotidine. It has been used as an analytical reagent for the determination of impurities in famotidine and other related compounds. Bis-[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]disulfide is soluble in methanol, ethanol and water, but not in acetone. The compound can be prepared by reacting 4-(dimethylamino)-1H-1,2,3-benzothiadiazole with 2-[(diaminomethylene)amino]-4-(N'-methoxycarbonylthio)benzaldehyde and then reductive amination with sodium bisulfite.Formula:C10H14N8S4Purity:Min. 95%Color and Shape:PowderMolecular weight:374.54 g/molCarbamazepine-10,11-epoxide-d10 (rings-d10)
CAS:Controlled ProductCarbamazepine-10,11-epoxide-d10 (rings-d10) is a metabolite of carbamazepine that has been shown to have pharmacological properties similar to those of the parent compound. It is used in drug development, metabolism studies, and as an impurity standard for pharmaceutical products. Carbamazepine-10,11-epoxide-d10 (rings-d10) is not found in nature and can be synthesized from carbamazepine. This metabolite has a purity of at least 98% and may be used as an analytical standard or as a research and development compound for pharmacopoeia.Formula:C15H2D10N2O2Purity:Min. 95%Molecular weight:262.33 g/mol4-Methyl-2-[3-[(1-methylethyl)amino]-1-phenylpropyl]phenol
CAS:4-Methyl-2-[3-[(1-methylethyl)amino]-1-phenylpropyl]phenol is a synthetic impurity standard that is used in the synthesis of drug products. This compound is also known as 4-methyl-2-[3-[(1-methylethyl)amino]-1-phenylpropyl]phenol and has a CAS number of 480432-14-2. It is used to verify the purity of drugs and drug products. 4MMPP can be found in pharmacopoeia, drug development, and metabolite studies. This compound is a research and development product for niche markets. 4MMPP can be obtained through custom synthesis or by synthesis.Formula:C19H25NOPurity:Min. 95%Molecular weight:283.41 g/molDexamethasone Acetate (Dexamethasone EP Impurity G, Betamethasone Acetate EP Impurity B)
CAS:Formula:C24H31FO6Color and Shape:White To Off-White SolidMolecular weight:434.50PROTOPORPHYRINATO ZINC
CAS:Formula:C34H32N4O4ZnPurity:98%Color and Shape:SolidMolecular weight:626.0223N-[2-(2-Methoxyphenoxy)ethyl]benzylamine
CAS:Applications Intermediate in the preparation of Carvedilol derivatives. References Mewshaw, R., et al.: J. Med. Chem., 47, 3823 (2004),Formula:C16H19NO2Color and Shape:NeatMolecular weight:257.328Blonanserin Impurity 4-d8
CAS:Formula:C21H18D8FN3Color and Shape:White To Off-White SolidMolecular weight:347.51Ropinirole aminoacetic acid
CAS:Ropinirole is an antiparkinsonian drug that is used for the treatment of Parkinson's disease. It is a synthetic drug, which has a chemical structure similar to natural dopamine. Ropinirole is metabolized in the liver via hydroxylation and oxidation to produce ropinirolone (CAS No. 920755-11-9). The main metabolites are ropinirolone and 2-hydroxypopinirolone. Ropinirole was approved by FDA in 1994.Formula:C16H26N2O2Purity:Min. 95%Molecular weight:278.39 g/molTacrolimus Impurity 1
CAS:Formula:C43H69NO11Color and Shape:White To Off-White SolidMolecular weight:776.02tert-butyl 3-amino-3-cyanoazetidine-1-carboxylate
CAS:Formula:C9H15N3O2Purity:97%Color and Shape:SolidMolecular weight:197.2343Fluocinonide Impurity 3
CAS:Formula:C26H31FO7Color and Shape:White To Off-White SolidMolecular weight:474.53Cimetidine Impurity 2
CAS:Formula:C4H5N3SColor and Shape:White To Off-White SolidMolecular weight:127.17